For simplicity, vaccinia virus (VV) genes are routinely grouped into early or late classes depending on whether their expression is independent of, or dependent on, viral DNA synthesis. Very little is known concerning the mechanisms which govern the switch between early and late gene expression modes during the VV replicative cycle. Recently a considerable amount of data has been obtained concerning the structure, nucleotide sequence, and regulation of some """"""""typical"""""""" early VV genetic loci. This information should provide the basis for the subsequent identification of VV early gene regulatory signals and the factors which recognize them. To date however, similar analyses have not been carried on the VV late genes. It is towards this problem that the experiments outlined in this proposal are directed. The genomic location of a number of VV late genes will be determined by two methods. First, DNA-mediated marker rescue techniques will be employed to map the positions of temperature-sensitive or drug-resistant VV mutants which exhibit a defective late phenotype in vivo. Second, VV late mRNA will be translated in cell-free protein synthesizing systems and late gene products identified on the basis of their enzymatic activities (virion enzymes) or polypeptide structure (e.g., VP62, or VP11). These cell-free assays can then be coupled with hybrid-arrest or hybrid-selection procedures in order to map these functions. Once representative VV late genes have been located, state-of-the-art recombinant DNA and molecular biology techniques will be used to study the structure of the transcriptional units, how they are expressed and regulated during infection, and the nature and activity of the encoded polypeptides. When compared and contrasted to the information already available concerning VV early genes, these results should provide some insight into the mechanisms which VV employs to achieve the ordered expression of it's complex developmental program within the infected cell.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI021335-03
Application #
3131337
Study Section
Experimental Virology Study Section (EVR)
Project Start
1983-12-01
Project End
1986-11-30
Budget Start
1985-12-01
Budget End
1986-11-30
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Oregon State University
Department
Type
Schools of Arts and Sciences
DUNS #
053599908
City
Corvallis
State
OR
Country
United States
Zip Code
97339
Alzhanova, Dina; Hruby, Dennis E (2007) A host cell membrane protein, golgin-97, is essential for poxvirus morphogenesis. Virology 362:421-7
Alzhanova, Dina; Hruby, Dennis E (2006) A trans-Golgi network resident protein, golgin-97, accumulates in viral factories and incorporates into virions during poxvirus infection. J Virol 80:11520-7
Blouch, Robert E; Byrd, Chelsea M; Hruby, Dennis E (2005) Importance of disulphide bonds for vaccinia virus L1R protein function. Virol J 2:91
Yoder, Jennifer D; Chen, Tsefang; Hruby, Dennis E (2004) Sequence-independent acylation of the vaccinia virus A-type inclusion protein. Biochemistry 43:8297-302
Chen, Tsefang F; Yoder, Jennifer D; Hruby, Dennis E (2004) Mass spectrometry analysis of synthetically myristoylated peptides. Eur J Mass Spectrom (Chichester, Eng) 10:501-8
Chen, Tsefang S; Yoder, Jennifer D; Hruby, Dennis E (2003) Preparation of a large hydrophobic protein for mass spectrometry analysis: vaccina virus ATI protein. Anal Biochem 315:277-80
Grosenbach, D W; Hansen, S G; Hruby, D E (2000) Identification and analysis of vaccinia virus palmitylproteins. Virology 275:193-206
Hansen, S G; Grosenbach, D W; Hruby, D E (1999) Analysis of the site occupancy constraints of primary amino acid sequences in the motif directing palmitylation of the vaccinia virus 37-kDa envelope protein. Virology 254:124-37
Martin, K H; Franke, C A; Hruby, D E (1999) Novel acylation of poxvirus A-type inclusion proteins. Virus Res 60:147-57
Grosenbach, D W; Hruby, D E (1998) Analysis of a vaccinia virus mutant expressing a nonpalmitylated form of p37, a mediator of virion envelopment. J Virol 72:5108-20

Showing the most recent 10 out of 27 publications